Characteristics | Recent users | Remote users | p-value |
N | 25 | 23 | – |
Male | 22 (88%) | 19 (83%) | 0.70 |
Age (years) | 49.6 ± 6.9 | 51.4 ± 6.3 | 0.35 |
Education (years) | 13.9 ± 2.2 | 14.6 ± 2.3 | 0.27 |
Caucasian race | 17 (68%) | 10 (44%) | 0.15 |
Years since HIV diagnosis | 13.1± 6.4 | 13.7 ± 7.4 | 0.79 |
Years on combination antiretroviral therapy | 11.0 ± 5.5 | 11.2 ± 6.7 | 0.92 |
Nadir CD4 count (cells/mm3), median (Q1 - Q3) | 175 (10 - 250) | 85.0 (50 - 245) | 0.71‡ |
Current CD4 count (cells/mm3), median (Q1 - Q3) | 466 (281 - 641) | 439 (325 - 592) | 0.98‡ |
Undetectable plasma HIV RNA (<50 copies/mL) | 22 (88%) | 18 (78%) | 0.45 |
Cannabis use | |||
Lifetime frequency of use (0 - 10 times) | 1 (4%) | 8 (35%) | 0.01 |
Lifetime frequency of use (>10 times) | 24 (96%) | 15 (65%) | 0.01 |
Duration of cannabis use (years) | 25 (5 - 30) | 8 (3 - 18) | 0.01‡ |